MWN109 clinical trials
How each study uses MWN109 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the MWN109 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2025 (5)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2, 1 in phase 3
Studies that test MWN109, phase 3 first.
- Sep 2027Phase 3 Study of MWN109 Injection in Participants With Overweight or ObesityPhase 3 · Shanghai Minwei Biotechnology Co., Ltd
- Mar 2027Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes MellitusPhase 2 · Shanghai Minwei Biotechnology Co., Ltd
Studies
Open first, then newest update. How each study uses MWN109 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes MellitusRecruitingPhase 2Shanghai Minwei Biotechnology Co., LtdNCT07801820Written as MWN109 1
- Phase 3 Study of MWN109 Injection in Participants With Overweight or ObesityNot yet recruitingPhase 3Shanghai Minwei Biotechnology Co., LtdNCT07778693Written as MWN109 1
- A Study to Evaluate MWN109 Tablets in Healthy Adult ParticipantsRecruitingPhase 1Shanghai Minwei Biotechnology Co., LtdNCT06938269Written as MWN109 tablet
- Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or ObesityCompletedPhase 1Shanghai Minwei Biotechnology Co., LtdNCT07787728Written as MWN109 1
- Phase 1 Clinical Study of MWN109 Injection in Healthy Chinese VolunteersCompletedPhase 1Shanghai Minwei Biotechnology Co., LtdNCT07787624Written as MWN109
- Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or ObesityActive, not recruitingPhase 2Shanghai Minwei Biotechnology Co., LtdNCT07804797Written as MWN109 1
- A Study to Evaluate Different Administration Conditions and the Food Effect of MWN109 Tablets in Chinese ParticipantsCompletedPhase 1Shanghai Minwei Biotechnology Co., LtdNCT07801326Written as MWN109 Tablets
- Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With OverweightActive, not recruitingPhase 2Shanghai Minwei Biotechnology Co., LtdNCT07791537Written as MWN109 1
- Phase 2 Study of MWN109 Tablet in Participants With Overweight or ObesityCompletedPhase 2Shanghai Minwei Biotechnology Co., LtdNCT07791524Written as MWN109 1
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or ObesityCompletedPhase 2Shanghai Minwei Biotechnology Co., LtdNCT07791654Written as MWN109 1
- Phase I Clinical Study of MWN109 Tablets in Healthy Chinese ParticipantsCompletedPhase 1Shanghai Minwei Biotechnology Co., LtdNCT07787611Written as MWN109 tablet